moxifloxacin has been researched along with Empyema, Gall Bladder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Encke, J; Gutt, C; Hoppe-Tichy, T; Köninger, J; Ober, MC; Schunter, O; Sonntag, HG; Swoboda, S; Weigand, MA | 1 |
| Ader, F; Bernard, L; Carlier, R; Perronne, C; Salomon, J; Toubiana, J | 1 |
2 other study(ies) available for moxifloxacin and Empyema, Gall Bladder
| Article | Year |
|---|---|
Tissue penetration of moxifloxacin into human gallbladder wall in patients with biliary tract infections.
Topics: Adult; Aged; Anti-Bacterial Agents; Aza Compounds; Bacterial Infections; Biliary Tract Diseases; Cholecystitis; Chromatography, High Pressure Liquid; Female; Fluoroquinolones; Gallbladder; Humans; Infusions, Intravenous; Male; Middle Aged; Moxifloxacin; Quinolines; Serum; Time Factors; Young Adult | 2009 |
[Cervical spondylodiscitis: one pathogen may hide another].
Topics: Anti-Bacterial Agents; Antitubercular Agents; Aza Compounds; Cervical Vertebrae; Cholecystitis; Discitis; Disease Progression; Drug Therapy, Combination; Escherichia coli; Escherichia coli Infections; Ethambutol; Fluoroquinolones; France; Humans; Immobilization; Isoniazid; Male; Middle Aged; Morocco; Moxifloxacin; Mycobacterium tuberculosis; Pyrazinamide; Quinolines; Radiography; Rifampin; Tuberculosis, Spinal | 2006 |